Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.

Kobayashi S, Hiwasa T, Ishige T, Rahmutulla B, Kano M, Hoshino T, Minamoto T, Shimada H, Nomura F, Matsubara H, Matsushita K.

Cancer Sci. 2019 Jun;110(6):2004-2013. doi: 10.1111/cas.14024. Epub 2019 May 20.

2.

Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients.

Kobayashi S, Hoshino T, Hiwasa T, Satoh M, Rahmutulla B, Tsuchida S, Komukai Y, Tanaka T, Matsubara H, Shimada H, Nomura F, Matsushita K.

Oncotarget. 2016 Dec 13;7(50):82493-82503. doi: 10.18632/oncotarget.12696.

3.

Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.

Ogura Y, Hoshino T, Tanaka N, Ailiken G, Kobayashi S, Kitamura K, Rahmutulla B, Kano M, Murakami K, Akutsu Y, Nomura F, Itoga S, Matsubara H, Matsushita K.

Oncotarget. 2018 May 1;9(33):22929-22944. doi: 10.18632/oncotarget.25149. eCollection 2018 May 1.

4.

SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.

Kajiwara T, Matsushita K, Itoga S, Tamura M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Habara Y, Matsuo M, Nomura F.

Cancer Sci. 2013 Feb;104(2):149-56. doi: 10.1111/cas.12058. Epub 2012 Dec 4.

5.

Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.

Zhou SL, Yue WB, Fan ZM, Du F, Liu BC, Li B, Han XN, Ku JW, Zhao XK, Zhang P, Cui J, Zhou FY, Zhang LQ, Fan XP, Zhou YF, Zhu LL, Liu HY, Wang LD.

Dis Esophagus. 2014 Nov-Dec;27(8):790-7. doi: 10.1111/dote.12145. Epub 2013 Oct 21.

PMID:
24147952
6.

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.

Dong J, Zeng BH, Xu LH, Wang JY, Li MZ, Zeng MS, Liu WL.

J Transl Med. 2010 Sep 3;8:81. doi: 10.1186/1479-5876-8-81.

7.

Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.

Matsushita K, Kitamura K, Rahmutulla B, Tanaka N, Ishige T, Satoh M, Hoshino T, Miyagi S, Mori T, Itoga S, Shimada H, Tomonaga T, Kito M, Nakajima-Takagi Y, Kubo S, Nakaseko C, Hatano M, Miki T, Matsuo M, Fukuyo M, Kaneda A, Iwama A, Nomura F.

Oncotarget. 2015 Mar 10;6(7):5102-17.

8.

Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.

Zhang JB, Cao M, Chen J, Ye SR, Xie K, He X, Ma XL, Zhang J, Yie SM.

Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):276-284. doi: 10.1016/j.clinre.2017.09.007. Epub 2017 Nov 21.

PMID:
29170084
9.

SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.

Matsushita K, Kajiwara T, Tamura M, Satoh M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Yoshimoto R, Ito A, Kubo S, Natsume T, Levens D, Yoshida M, Nomura F.

Mol Cancer Res. 2012 Jun;10(6):787-99. doi: 10.1158/1541-7786.MCR-11-0462. Epub 2012 Apr 11.

10.

Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.

Gao H, Zheng Z, Mao Y, Wang W, Qiao Y, Zhou L, Liu F, He H, Zhao X.

Cancer Lett. 2014 Mar 1;344(1):54-61. doi: 10.1016/j.canlet.2013.10.007. Epub 2013 Oct 22.

PMID:
24157810
11.

Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.

Matsushita K, Tamura M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Levens D, He L, Liu J, Yoshida M, Nomura F.

Mol Cancer Res. 2013 Jul;11(7):689-98. doi: 10.1158/1541-7786.MCR-12-0673. Epub 2013 Apr 17.

12.

Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.

Rahmutulla B, Matsushita K, Satoh M, Seimiya M, Tsuchida S, Kubo S, Shimada H, Ohtsuka M, Miyazaki M, Nomura F.

Oncotarget. 2014 May 15;5(9):2404-17.

13.

Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.

Chai Y, Peng B, Dai L, Qian W, Zhang Y, Zhang JY.

Scand J Immunol. 2014 Nov;80(5):362-8. doi: 10.1111/sji.12202.

14.

PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.

Fiorentino DF, Presby M, Baer AN, Petri M, Rieger KE, Soloski M, Rosen A, Mammen AL, Christopher-Stine L, Casciola-Rosen L.

Ann Rheum Dis. 2016 Jun;75(6):1145-51. doi: 10.1136/annrheumdis-2015-207509. Epub 2015 Aug 7.

15.

Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.

Zhou JH, Zhang B, Kernstine KH, Zhong L.

World J Gastroenterol. 2011 Mar 14;17(10):1373-8. doi: 10.3748/wjg.v17.i10.1373.

16.

Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.

Peng YH, Xu YW, Guo H, Huang LS, Tan HZ, Hong CQ, Li SS, Xu LY, Li EM.

Cancer Med. 2016 Jul;5(7):1388-96. doi: 10.1002/cam4.702. Epub 2016 Mar 14.

17.

Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.

Chen WX, Hong XB, Hong CQ, Liu M, Li L, Huang LS, Xu LY, Xu YW, Peng YH, Li EM.

Clin Res Hepatol Gastroenterol. 2017 Jun;41(3):327-332. doi: 10.1016/j.clinre.2016.10.011. Epub 2016 Dec 9.

PMID:
27956255
18.

Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma.

Liu WL, Zhang G, Wang JY, Cao JY, Guo XZ, Xu LH, Li MZ, Song LB, Huang WL, Zeng MS.

Biochem Biophys Res Commun. 2008 Oct 24;375(3):440-5. doi: 10.1016/j.bbrc.2008.08.039. Epub 2008 Aug 21.

PMID:
18722351
19.

Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.

Kobayashi S, Hiwasa T, Arasawa T, Kagaya A, Ishii S, Shimada H, Ito M, Suzuki M, Kano M, Rahmutulla B, Kitamura K, Sawabe Y, Shin H, Takiguchi M, Nomura F, Matsubara H, Matsushita K.

Oncotarget. 2018 Jan 1;9(26):18559-18569. doi: 10.18632/oncotarget.24963. eCollection 2018 Apr 6.

20.

[Alternative Splicing Detection as Biomarker Candidates for Cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].

Matsushita K, Itoga S, Nishimura M, Furuta K, Nomura F.

Rinsho Byori. 2015 Mar;63(3):347-60. Review. Japanese.

PMID:
26524858

Supplemental Content

Support Center